Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000121446 | SCV000112007 | benign | not specified | 2015-04-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000878916 | SCV001021907 | likely benign | Kabuki syndrome | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705745 | SCV001890694 | benign | not provided | 2019-07-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483140 | SCV002795091 | likely benign | Kabuki syndrome 1 | 2021-10-12 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121446 | SCV000085640 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV004537341 | SCV004743140 | likely benign | KMT2D-related disorder | 2019-09-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |